News

'No evidence' to support polyclinics

05-Jun-08

Professor Martin Roland
Researchers warn that polyclinics could worsen access, increase cost and damage care.

Moving GPs into polyclinics could worsen access, increase costs and damage care, according to an influential think tank.

The King's Fund report, 'Under One Roof: will polyclinics deliver integrated care?', says that there are 'compelling arguments' for providing integrated health services closer to patients' homes.

But it warns that there is no evidence that larger GP practices provide better services, and argues that 'a major centralisation of primary care is unlikely to be beneficial to patients'.

The report calls for PCTs to abandon plans to concentrate GP services into larger sites. Instead they should pilot several models, such as hub-and-spoke and 'virtual' polyclinics, it says.

Dr Niall Dickson, the King's Fund's chief executive, called for ministers to spell out 'in unequivocal terms' that PCTs will not be forced to build the new centres.

The report examines polyclinics abroad, as well as health centres built under Local Improvement Finance Trusts.

It argues that the planned reforms will not improve services without clinician support.

Other experts have echoed the report's suggestion that policy should focus on redesigning services, instead of just moving them to new buildings.

Professor Martin Roland, director of the National Primary Care Research and Development Centre, said at an event hosted by the think tank Civitas last week that polyclinics risked becoming an 'expensive exercise in building new buildings without clear thought about what they would do'.

GPC chairman Dr Laurence Buckman said: 'The report provides scientific, logical and international evidence that polyclinics won't deliver the things the government believes they will.'

But he added: 'This government doesn't listen to evidence.'

A DoH spokesman said it was not policy to impose polyclinics outside London.

jonn.elledge@haymarket.com

Kings Fund report

Polyclinic risks

  • Benefits of co-location not realised because of poor planning.
  • Access to GP services damaged in rural areas.
  • Potential increase in costs.
  • Co-location does not mean more co-operation.
    Source: King's Fund.

Comment below and tell us what you think

Comments

Mary Hawking

05/06/2008

Isn't one of the problems funding streams?

If you look at the development of services outside hospitals from the financial point of view, where is the funding to come from?

Services may be cheaper - but there are difficulties in removing funding from secondary care for any reason - and the savings would only be the difference between the PBR and commissioned rates: almost certainly insufficient to support a polyclinic of any sort.

On the other hand, by co-locating a large number of GPs, use can be made of the existing premises funding - so the additional cost of providing space for other services is greatly decreased.

Add in a bit of commerce - say a branch of a large chain pharmacy (*so* convenient for the patients!) - and the project begins to look financially viable.

If you leave out GP rents, would the sums add up?

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

Golden rules for registrars

Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more

Career paths - Working abroad in a rural practice

Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more

Professional development - Honing your presentation skills

Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more

Show all articles

 

Latest Clinical Articles

Clinical Review - Malaria

Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Show all clinical articles

MIMS Product News

New drug - Xamiol

Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more

New drug - Xarelto

Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more

New drug - Torisel

Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more

Jobs

 

Job of the Week